ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine

This study has been completed.
Study NCT00475514.   Last updated on May 17, 2007.   Information provided by Endo Pharmaceuticals

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Migraine
2 Additional conditions recognized in this trial
Migraine Disorders
3 More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Headache Disorders
Headache Disorders, Primary
Nervous System Diseases
4 Interventions listed in this trial
Frovatriptan 2.5mg QD
Frovatriptan 2.5 mg BID
placebo
5 Additional drug interventions recognized in this trial
Frovatriptan
6 More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Serotonin Agents
Serotonin Agonists
7 Sponsors listed in this trial
Endo Pharmaceuticals




Links to all studies - primarily for crawlers